BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Sep 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-09-22

Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-22	Common Stock	M	1355	$37.46	Acquired	49299	Direct
2017-09-22	Common Stock	S	1355	$95.00	Disposed	47944	Direct
2017-09-22	Common Stock	M	2166	$37.46	Acquired	50110	Direct
2017-09-22	Common Stock	S	2166	$95.00	Disposed	47944	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-22	Stock Option (Right to buy Common Stock)	$37.46	M	1355	Disposed	2022-05-07	Common Stock (1355)	Direct
2017-09-22	Stock Option (Right to buy Common Stock)	$37.46	M	2166	Disposed	2022-05-07	Common Stock (2166)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

F2: All shares were sold at the same price.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.